The drug “Ozempik” can help with kidney and liver diseases: scientists

The photo is illustrative

Syda_Productions/DEPOSITPHOTOS

Scientists discovered that the drug for the treatment of diabetes Ozempic company Novo Nordisk slows down the progression of chronic kidney disease in patients.

In addition, it can reduce the risk of death from heart disease, as well as improve liver health in people with HIV, he writes Reuters.

Ozempic is a drug of the GLP-1 class with the active substance semaglutide, which is prescribed to patients in the form of a weekly injection.

A study found that a weekly injection of semaglutide reduced the risk of death from chronic kidney disease as well as heart disease in patients with type II diabetes by 24%.

The study, called FLOW, began in 2019 and included about 3,500 patients with type II diabetes and moderate to severe chronic kidney disease.

Participants received 1 milligram (mg) of semaglutide once weekly in addition to standard treatment.

“The positive results of the FLOW trial suggest that semaglutide may be a first-line GLP-1 treatment option for people living with type 2 diabetes and chronic kidney disease,” – said the head of Novo’s development department Nordisk Martin Holst Lange.

One more research has shown that Ozempic helps improve the condition of the liver in people with OX.

A weekly injection of semaglutide reduced the amount of fat in the liver of study participants by 31%.

This is the first study to show the effects of semaglutide in HIV-infected patients with metabolic dysfunction associated with fatty liver disease (MASLD). Clinical trials were funded by the National Institutes of Health.

As a reminder, the drug Ozempic helps the pancreas produce more insulin and helps lower blood sugar. Its primary purpose is the treatment of diabetes and obesity.

However, scientists have evidence that such drugs can have medical benefits for other conditions as well.

Now Ozempic approved by the US regulator to lower blood sugar in adults with type 2 diabetes, in addition to diet and exercise.

It has also been approved for use to reduce the risk of heart attack, stroke or death in people with diabetes or heart disease.

Previously, scientists decided to investigate whether such drugs (Ozempic and Wegovy in particular) contribute to the appearance suicidal thoughts.

Importantly! This material is based on the latest and current scientific research, is of an informational and reference nature only and cannot be the basis for establishing a medical diagnosis. To establish a diagnosis and receive treatment, be sure to consult a doctor!